Business
BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre Hotel
TORONTO, ON / ACCESSWIRE / June 13, 2018 / BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: ...
About this update from Briacell Therapeutics Corp
[{"type":"text","content":"BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre HotelTORONTO, ON / ACCESSWIRE / June 13, 2018 / BriaCell Therapeutics Corp. (\"BriaCell\") (TSX-V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, will be presenting at this year's MicroCap Conference on June 21st in Toronto, Canada. Dr. Bill Williams, BriaCell's President and CEO will discuss Bria-IMT™, BriaCell's lead clinical candidate, its potential in treating breast cancer, and its advantages over similar immuno-oncology therapeutics. He will also discuss the clinical development plans for Bria-OTS™, the first off-the-shelf personalized immunotherapy in development for advanced breast cancer. Additionally, Dr. Williams will discuss the promising clinical data in the ongoing clinical studies of Bia-IMT™ in advanced breast cancer.BriaCell is a clinical stage immuno-oncology focused biotechnology company developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer. The company is conducting a Phase IIa clinical trial for its lead product candidate, Bria-IMT™, in advanced breast cancer along with the co-development of BriaDX™, its companion diagnostic. Additionally, there is an FDA approved combination study of Bria-IMT™ with pembrolizumab or ipilimumab for patients with advanced breast cancer previously treated with Bria-IMT™. BriaCell is developing Bria-OTS™, the first off-the-shelf personalized treatment for advanced breast cancer. BriaCell's small molecule program consists of novel, selective protein kinase C delta inhibitors which have shown activity in pre-clinical models of several cancers and fibrotic diseases.CONFERENCE OVERVIEW AND STRUCTUREThe MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.The MicroCap Conference will take place in Toronto at the Sheraton Centre Hotel on June 21st. Registration will begin on Thursday at 7:00AM and will last until the evening. These days will be jam-packed with company p...